About
IconOVir Bio develops antibody-drug conjugates (ADCs) for oncology, focusing on targeted therapies to treat and eliminate tumor cells in cancer patients.
Explore IconOVir Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.